251 related articles for article (PubMed ID: 37148581)
21. Novel formulations of metal-organic frameworks for controlled drug delivery.
Rao C; Liao D; Pan Y; Zhong Y; Zhang W; Ouyang Q; Nezamzadeh-Ejhieh A; Liu J
Expert Opin Drug Deliv; 2022 Oct; 19(10):1183-1202. PubMed ID: 35426756
[TBL] [Abstract][Full Text] [Related]
22. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
Wu MX; Yang YW
Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
[TBL] [Abstract][Full Text] [Related]
23. The impact of MOFs in pH-dependent drug delivery systems: progress in the last decade.
De D; Sahoo P
Dalton Trans; 2022 Jul; 51(26):9950-9965. PubMed ID: 35726742
[TBL] [Abstract][Full Text] [Related]
24. Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes.
Coluccia M; Parisse V; Guglielmi P; Giannini G; Secci D
Eur J Med Chem; 2022 Dec; 244():114801. PubMed ID: 36215860
[TBL] [Abstract][Full Text] [Related]
25. Antitumor Agents Based on Metal-Organic Frameworks.
Gao P; Chen Y; Pan W; Li N; Liu Z; Tang B
Angew Chem Int Ed Engl; 2021 Jul; 60(31):16763-16776. PubMed ID: 33686725
[TBL] [Abstract][Full Text] [Related]
26. Copper-based metal-organic frameworks for biomedical applications.
Cun JE; Fan X; Pan Q; Gao W; Luo K; He B; Pu Y
Adv Colloid Interface Sci; 2022 Jul; 305():102686. PubMed ID: 35523098
[TBL] [Abstract][Full Text] [Related]
27. Applications of nanoscale metal-organic frameworks as imaging agents in biology and medicine.
Demir Duman F; Forgan RS
J Mater Chem B; 2021 Apr; 9(16):3423-3449. PubMed ID: 33909734
[TBL] [Abstract][Full Text] [Related]
28. Nanoscale metal-organic frameworks for tumor phototherapy.
Huang X; Sun X; Wang W; Shen Q; Shen Q; Tang X; Shao J
J Mater Chem B; 2021 May; 9(18):3756-3777. PubMed ID: 33870980
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in porous MOFs and their hybrids for photothermal cancer therapy.
Su J; Jing P; Jiang K; Du J
Dalton Trans; 2022 Jun; 51(23):8938-8944. PubMed ID: 35642650
[TBL] [Abstract][Full Text] [Related]
30. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
[TBL] [Abstract][Full Text] [Related]
31. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
Carrillo-Carrión C
Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
[TBL] [Abstract][Full Text] [Related]
32. Nanoscale MOFs: From synthesis to drug delivery and theranostics applications.
Ding M; Liu W; Gref R
Adv Drug Deliv Rev; 2022 Nov; 190():114496. PubMed ID: 35970275
[TBL] [Abstract][Full Text] [Related]
33. Advances and Applications of Metal-Organic Framework Nanomaterials as Oral Delivery Carriers: A Review.
Li L; Qi Z; Han S; Li X; Liu B; Liu Y
Mini Rev Med Chem; 2022; 22(20):2564-2580. PubMed ID: 35362373
[TBL] [Abstract][Full Text] [Related]
34. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
[TBL] [Abstract][Full Text] [Related]
35. Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy.
Cai W; Gao H; Chu C; Wang X; Wang J; Zhang P; Lin G; Li W; Liu G; Chen X
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2040-2051. PubMed ID: 28032505
[TBL] [Abstract][Full Text] [Related]
36. Curcumin Delivery on Metal-Organic Frameworks: The Effect of the Metal Center on Pharmacokinetics within the M-MOF-74 Family.
Lawson S; Newport K; Pederniera N; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2021 Apr; 4(4):3423-3432. PubMed ID: 35014426
[TBL] [Abstract][Full Text] [Related]
37. Metal-Organic Frameworks as Platforms for Catalytic Applications.
Jiao L; Wang Y; Jiang HL; Xu Q
Adv Mater; 2018 Sep; 30(37):e1703663. PubMed ID: 29178384
[TBL] [Abstract][Full Text] [Related]
38. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
[TBL] [Abstract][Full Text] [Related]
39. Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy.
Zeng L; Cao Y; He L; Ding S; Bian XW; Tian G
J Mater Chem B; 2021 Jan; 9(2):208-227. PubMed ID: 33215626
[TBL] [Abstract][Full Text] [Related]
40. Metalloporphyrinic metal-organic frameworks: Controlled synthesis for catalytic applications in environmental and biological media.
Younis SA; Lim DK; Kim KH; Deep A
Adv Colloid Interface Sci; 2020 Mar; 277():102108. PubMed ID: 32028075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
